[1] Marcu DTM,Adam CA,Mitu F,et al.Cardiovascular Involvement in Tuberculosis:From Pathophysiology to Diagnosis and Complications-A Narrative Review.Diagnostics(Basel),2023,13(3):432. [2] Mondoni M,Albrici C,Terraneo S,et al.Prevalence and short-term outcomes of acute complications of tuberculosis:a cross-sectional,monocentre,Italian study.BMC Infect Dis,2025,25(1):564. [3] 中华人民共和国国家卫生和计划生育委员会.WS 288—2017 肺结核诊断.结核与肺部疾病杂志,2024,5(4):376-378. [4] McDonagh TA,Metra M,Adamo M,et al.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J,2021,42(36):3599-3726. [5] 中国疾病预防控制中心.中国结核病防治工作技术指南.北京:人民卫生出版社,2021:240-262. [6] Wen-Ting L,Chang-Wei W,De-Jian B,et al.Arterial partial pressure of oxygen and procalcitonin levels correlate with pulmonary artery systolic pressure in patients with active pulmonary tuberculosis.Int J Infect Dis,2022,117:87-92. [7] Belinskaia DA,Jenkins RO,Goncharov NV.Albumin Is an Integrative Protein of Blood Plasma and Beyond.Int J Mol Sci,2024,25(23):12627. [8] Cho H,Jeon SI,Ahn CH,et al.Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery:Current Understandings and Clinical Translation.Pharmaceutics,2022,14(4):728. [9] Zhao W,Qin J,Lu G,et al.Association between hyponatremia and adverse clinical outcomes of heart failure:current evidence based on a systematic review and meta-analysis.Front Cardiovasc Med,2023,10:1339203. [10] 中华医学会结核病学分会.抗结核药所致药物性肝损伤诊治指南(2024年版).中华结核和呼吸杂志,2024,47(11):1069-1090. [11] 王立红,肖开提·米吉提,郑甜,等.一对一护理干预对住院肺结核患者营养改善的影响.中国防痨杂志,2024,46(S1):297-299. [12] Brailey PM,Evans L,López-Rodríguez JC,et al.CD1d-dependent rewiring of lipid metabolism in macrophages regulates innate immune responses.Nat Commun,2022,13(1):6723. [13] Wang B,Guo Z,Liu J,et al.Mild Malnutrition Contributes the Greatest to the Poor Prognosis in Coronary Artery Disease With Well-Controlled Low-Density Lipoprotein Cholesterol Levels:A 4,863 Chinese Cohort Study.Front Nutr,2021,8:725537. [14] Dhanyalayam D,Thangavel H,Sidrat T,et al.The Influence of Body Fat Dynamics on Pulmonary Immune Responses in Murine Tuberculosis:Unraveling Sex-Specific Insights.Int J Mol Sci,2024,25(13):6823. [15] Alffenaar JC,de Steenwinkel JEM,Diacon AH,et al.Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs:An evaluation of in vitro,in vivo methodologies and human studies.Front Pharmacol,2022,13:1063453. [16] Ahmed N,Amjad I,Abbas Malik Z,et al.Effects of Anti-Tuberculosis Drugs on Lipid Profile in Pulmonary Tuberculosis Patients.J.Dow Univ.Health Sci,2022,16(2):78-82. [17] Araújo-Pereira M,Nogueira BMF,Spener-Gomes R,et al.Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis:A multi-center prospective cohort study.J Infect Public Health,2023,16(6):974-980. [18] Ashenafi S,Bekele A,Aseffa G,et al.Anemia Is a Strong Predictor of Wasting,Disease Severity,and Progression,in Clinical Tuberculosis(TB).Nutrients,2022,14(16):3318. [19] Kheradmand M,Afshari M,Aarabi M,et al.Incidence of side effects of antituberculosis drugs and their related factors in northern Iran:a retrospective cohort study.GMS Hyg Infect Control,2024:19. [20] Butzner M,Riello RJ 3rd,Sarocco P,et al.Adverse drug effects across patients with heart failure:a systematic review.Am J Manag Care,2022,28(3):e113-e120. [21] Cheko J,Patsalis N,Kreutz J,et al.The Impact of Positive Inotropic Therapy on Hemodynamics and Organ Function in Acute Heart Failure:A Differentiated View.J Pers Med,2023,14(1):17. [22] 黄毅,左蕾,崔文琦.结核性胸膜炎超声诊断、分型及介入治疗专家共识(2022年版).中国防痨杂志,2022,44(9):880-897. |